6-43007960-A-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_006245.4(PPP2R5D):c.752A>T(p.Asp251Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D251N) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006245.4 missense
Scores
Clinical Significance
Conservation
Publications
- Hogue-Janssens syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PPP2R5D | NM_006245.4 | c.752A>T | p.Asp251Val | missense_variant | Exon 7 of 16 | ENST00000485511.6 | NP_006236.1 | |
| PPP2R5D | NM_180976.3 | c.656A>T | p.Asp219Val | missense_variant | Exon 7 of 16 | NP_851307.1 | ||
| PPP2R5D | NM_180977.3 | c.434A>T | p.Asp145Val | missense_variant | Exon 5 of 14 | NP_851308.1 | ||
| PPP2R5D | NM_001270476.2 | c.299A>T | p.Asp100Val | missense_variant | Exon 7 of 16 | NP_001257405.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hogue-Janssens syndrome 1 Pathogenic:3Uncertain:1
- -
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-11-05 and interpreted as Likely Pathogenic. The reporting laboratory might also submit to ClinVar. This variant was identified in multiple probands enrolled in Simons Searchlight. -
- -
- -
not provided Pathogenic:1Uncertain:1
The D251V variant in the PPP2R5D gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The D251V variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D251V variant is a non-conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. The D251V variant is a strong candidate for a pathogenic variant, -
This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 251 of the PPP2R5D protein (p.Asp251Val). This missense change has been observed in individual(s) with clinical features of PPP2R5D-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 420814). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant disrupts the p.Asp251 amino acid residue in PPP2R5D. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at